Switch to:
Also traded in: Germany, USA

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.01
UHS's Cash to Debt is ranked lower than
97% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 0.29 vs. UHS: 0.01 )
Ranked among companies with meaningful Cash to Debt only.
UHS' s Cash to Debt Range Over the Past 10 Years
Min: 0  Med: 0.01 Max: 0.27
Current: 0.01
0
0.27
Equity to Asset 0.45
UHS's Equity to Asset is ranked higher than
51% of the 219 Companies
in the Global Medical Care industry.

( Industry Median: 0.45 vs. UHS: 0.45 )
Ranked among companies with meaningful Equity to Asset only.
UHS' s Equity to Asset Range Over the Past 10 Years
Min: 0.26  Med: 0.42 Max: 0.49
Current: 0.45
0.26
0.49
Interest Coverage 9.01
UHS's Interest Coverage is ranked lower than
51% of the 157 Companies
in the Global Medical Care industry.

( Industry Median: 9.36 vs. UHS: 9.01 )
Ranked among companies with meaningful Interest Coverage only.
UHS' s Interest Coverage Range Over the Past 10 Years
Min: 4.47  Med: 7.44 Max: 11.36
Current: 9.01
4.47
11.36
F-Score: 8
Z-Score: 2.80
M-Score: -5.02
WACC vs ROIC
6.90%
11.71%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating margin (%) 14.26
UHS's Operating margin (%) is ranked higher than
75% of the 219 Companies
in the Global Medical Care industry.

( Industry Median: 7.46 vs. UHS: 14.26 )
Ranked among companies with meaningful Operating margin (%) only.
UHS' s Operating margin (%) Range Over the Past 10 Years
Min: 7.71  Med: 9.55 Max: 13.94
Current: 14.26
7.71
13.94
Net-margin (%) 7.69
UHS's Net-margin (%) is ranked higher than
68% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 4.28 vs. UHS: 7.69 )
Ranked among companies with meaningful Net-margin (%) only.
UHS' s Net-margin (%) Range Over the Past 10 Years
Min: 3.64  Med: 5.72 Max: 7.01
Current: 7.69
3.64
7.01
ROE (%) 17.48
UHS's ROE (%) is ranked higher than
75% of the 204 Companies
in the Global Medical Care industry.

( Industry Median: 9.24 vs. UHS: 17.48 )
Ranked among companies with meaningful ROE (%) only.
UHS' s ROE (%) Range Over the Past 10 Years
Min: 11.67  Med: 16.47 Max: 19.9
Current: 17.48
11.67
19.9
ROA (%) 7.50
UHS's ROA (%) is ranked higher than
70% of the 222 Companies
in the Global Medical Care industry.

( Industry Median: 3.42 vs. UHS: 7.50 )
Ranked among companies with meaningful ROA (%) only.
UHS' s ROA (%) Range Over the Past 10 Years
Min: 4.01  Med: 5.89 Max: 8.46
Current: 7.5
4.01
8.46
ROC (Joel Greenblatt) (%) 30.48
UHS's ROC (Joel Greenblatt) (%) is ranked higher than
63% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 19.71 vs. UHS: 30.48 )
Ranked among companies with meaningful ROC (Joel Greenblatt) (%) only.
UHS' s ROC (Joel Greenblatt) (%) Range Over the Past 10 Years
Min: 12.5  Med: 22.67 Max: 26.43
Current: 30.48
12.5
26.43
Revenue Growth (3Y)(%) 1.80
UHS's Revenue Growth (3Y)(%) is ranked lower than
75% of the 160 Companies
in the Global Medical Care industry.

( Industry Median: 8.20 vs. UHS: 1.80 )
Ranked among companies with meaningful Revenue Growth (3Y)(%) only.
UHS' s Revenue Growth (3Y)(%) Range Over the Past 10 Years
Min: 1.8  Med: 14.00 Max: 18.7
Current: 1.8
1.8
18.7
EBITDA Growth (3Y)(%) 5.70
UHS's EBITDA Growth (3Y)(%) is ranked lower than
58% of the 128 Companies
in the Global Medical Care industry.

( Industry Median: 7.90 vs. UHS: 5.70 )
Ranked among companies with meaningful EBITDA Growth (3Y)(%) only.
UHS' s EBITDA Growth (3Y)(%) Range Over the Past 10 Years
Min: -3.3  Med: 14.20 Max: 26.7
Current: 5.7
-3.3
26.7
EPS Growth (3Y)(%) 10.30
UHS's EPS Growth (3Y)(%) is ranked higher than
53% of the 121 Companies
in the Global Medical Care industry.

( Industry Median: 9.00 vs. UHS: 10.30 )
Ranked among companies with meaningful EPS Growth (3Y)(%) only.
UHS' s EPS Growth (3Y)(%) Range Over the Past 10 Years
Min: -9.9  Med: 15.25 Max: 29.8
Current: 10.3
-9.9
29.8
» UHS's 10-Y Financials

Financials (Next Earnings Date: 2016-02-26)


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2015

UHS Guru Trades in Q1 2015

Larry Robbins 974,960 sh (+139.57%)
Paul Tudor Jones 8,544 sh (+76.53%)
Lee Ainslie 969,941 sh (+16.19%)
Vanguard Health Care Fund 4,053,000 sh (unchged)
Robert Olstein 62,000 sh (unchged)
Andreas Halvorsen Sold Out
Ron Baron 413,187 sh (-0.01%)
Chris Davis 118,990 sh (-0.09%)
RS Investment Management 237,942 sh (-1.18%)
Westport Asset Management 754,584 sh (-1.31%)
Private Capital 214,499 sh (-12.17%)
Joel Greenblatt 224,821 sh (-22.55%)
Mariko Gordon 36,833 sh (-24.34%)
Jim Simons 108,000 sh (-32.29%)
» More
Q2 2015

UHS Guru Trades in Q2 2015

Andreas Halvorsen 1,220,743 sh (New)
Louis Moore Bacon 49,147 sh (New)
Paul Tudor Jones 12,791 sh (+49.71%)
Lee Ainslie 1,016,491 sh (+4.80%)
Private Capital 219,664 sh (+2.41%)
Vanguard Health Care Fund 4,128,600 sh (+1.87%)
Mariko Gordon Sold Out
Jim Simons Sold Out
Larry Robbins 971,787 sh (-0.33%)
Ron Baron 409,618 sh (-0.86%)
Chris Davis 114,880 sh (-3.45%)
Westport Asset Management 724,584 sh (-3.98%)
RS Investment Management 198,786 sh (-16.46%)
RS Investment Management 198,786 sh (-16.46%)
Robert Olstein 41,000 sh (-33.87%)
Joel Greenblatt 105,662 sh (-53.00%)
» More
Q3 2015

UHS Guru Trades in Q3 2015

Ray Dalio 8,200 sh (New)
RS Investment Management 264,866 sh (+33.24%)
Private Capital 223,171 sh (+1.60%)
Ron Baron 409,748 sh (+0.03%)
Andreas Halvorsen Sold Out
Louis Moore Bacon Sold Out
Larry Robbins 964,895 sh (-0.71%)
Vanguard Health Care Fund 3,939,340 sh (-4.58%)
Westport Asset Management 685,391 sh (-5.41%)
Lee Ainslie 908,071 sh (-10.67%)
Chris Davis 82,120 sh (-28.52%)
Robert Olstein 20,600 sh (-49.76%)
Paul Tudor Jones 5,000 sh (-60.91%)
Joel Greenblatt 22,289 sh (-78.91%)
» More
Q4 2015

UHS Guru Trades in Q4 2015

Vanguard Health Care Fund 3,939,340 sh (unchged)
» More
» Details

Insider Trades

Latest Guru Trades with UHS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/E(ttm) 16.20
UHS's P/E(ttm) is ranked higher than
78% of the 152 Companies
in the Global Medical Care industry.

( Industry Median: 25.00 vs. UHS: 16.20 )
Ranked among companies with meaningful P/E(ttm) only.
UHS' s P/E(ttm) Range Over the Past 10 Years
Min: 8.06  Med: 14.01 Max: 25.79
Current: 16.2
8.06
25.79
Forward P/E 13.42
UHS's Forward P/E is ranked higher than
66% of the 98 Companies
in the Global Medical Care industry.

( Industry Median: 15.67 vs. UHS: 13.42 )
Ranked among companies with meaningful Forward P/E only.
N/A
PE(NRI) 16.20
UHS's PE(NRI) is ranked higher than
79% of the 154 Companies
in the Global Medical Care industry.

( Industry Median: 25.00 vs. UHS: 16.20 )
Ranked among companies with meaningful PE(NRI) only.
UHS' s PE(NRI) Range Over the Past 10 Years
Min: 8.22  Med: 15.21 Max: 28.78
Current: 16.2
8.22
28.78
P/B 2.60
UHS's P/B is ranked lower than
52% of the 198 Companies
in the Global Medical Care industry.

( Industry Median: 2.53 vs. UHS: 2.60 )
Ranked among companies with meaningful P/B only.
UHS' s P/B Range Over the Past 10 Years
Min: 1.01  Med: 2.12 Max: 3.54
Current: 2.6
1.01
3.54
P/S 1.24
UHS's P/S is ranked higher than
56% of the 220 Companies
in the Global Medical Care industry.

( Industry Median: 1.47 vs. UHS: 1.24 )
Ranked among companies with meaningful P/S only.
UHS' s P/S Range Over the Past 10 Years
Min: 0.33  Med: 0.75 Max: 1.7
Current: 1.24
0.33
1.7
PFCF 22.96
UHS's PFCF is ranked lower than
62% of the 116 Companies
in the Global Medical Care industry.

( Industry Median: 17.69 vs. UHS: 22.96 )
Ranked among companies with meaningful PFCF only.
UHS' s PFCF Range Over the Past 10 Years
Min: 8.5  Med: 16.89 Max: 296.78
Current: 22.96
8.5
296.78
POCF 9.62
UHS's POCF is ranked higher than
72% of the 158 Companies
in the Global Medical Care industry.

( Industry Median: 14.01 vs. UHS: 9.62 )
Ranked among companies with meaningful POCF only.
UHS' s POCF Range Over the Past 10 Years
Min: 3.2  Med: 8.09 Max: 24.85
Current: 9.62
3.2
24.85
EV-to-EBIT 10.79
UHS's EV-to-EBIT is ranked higher than
85% of the 171 Companies
in the Global Medical Care industry.

( Industry Median: 17.86 vs. UHS: 10.79 )
Ranked among companies with meaningful EV-to-EBIT only.
UHS' s EV-to-EBIT Range Over the Past 10 Years
Min: 6.3  Med: 11.00 Max: 20
Current: 10.79
6.3
20
EV-to-EBITDA 8.26
UHS's EV-to-EBITDA is ranked higher than
81% of the 181 Companies
in the Global Medical Care industry.

( Industry Median: 12.41 vs. UHS: 8.26 )
Ranked among companies with meaningful EV-to-EBITDA only.
UHS' s EV-to-EBITDA Range Over the Past 10 Years
Min: 4.3  Med: 7.80 Max: 11.6
Current: 8.26
4.3
11.6
PEG 1.01
UHS's PEG is ranked higher than
76% of the 76 Companies
in the Global Medical Care industry.

( Industry Median: 2.76 vs. UHS: 1.01 )
Ranked among companies with meaningful PEG only.
UHS' s PEG Range Over the Past 10 Years
Min: 0.41  Med: 1.03 Max: 4.1
Current: 1.01
0.41
4.1
Shiller P/E 29.49
UHS's Shiller P/E is ranked lower than
56% of the 41 Companies
in the Global Medical Care industry.

( Industry Median: 24.06 vs. UHS: 29.49 )
Ranked among companies with meaningful Shiller P/E only.
UHS' s Shiller P/E Range Over the Past 10 Years
Min: 10.2  Med: 21.40 Max: 40.68
Current: 29.49
10.2
40.68
Current Ratio 1.42
UHS's Current Ratio is ranked higher than
55% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 1.33 vs. UHS: 1.42 )
Ranked among companies with meaningful Current Ratio only.
UHS' s Current Ratio Range Over the Past 10 Years
Min: 1.06  Med: 1.56 Max: 1.98
Current: 1.42
1.06
1.98
Quick Ratio 1.32
UHS's Quick Ratio is ranked higher than
56% of the 221 Companies
in the Global Medical Care industry.

( Industry Median: 1.22 vs. UHS: 1.32 )
Ranked among companies with meaningful Quick Ratio only.
UHS' s Quick Ratio Range Over the Past 10 Years
Min: 0.95  Med: 1.43 Max: 1.78
Current: 1.32
0.95
1.78
Days Inventory 41.46
UHS's Days Inventory is ranked lower than
72% of the 158 Companies
in the Global Medical Care industry.

( Industry Median: 16.82 vs. UHS: 41.46 )
Ranked among companies with meaningful Days Inventory only.
UHS' s Days Inventory Range Over the Past 10 Years
Min: 8.27  Med: 9.47 Max: 42.77
Current: 41.46
8.27
42.77
Days Sales Outstanding 54.87
UHS's Days Sales Outstanding is ranked lower than
62% of the 188 Companies
in the Global Medical Care industry.

( Industry Median: 46.01 vs. UHS: 54.87 )
Ranked among companies with meaningful Days Sales Outstanding only.
UHS' s Days Sales Outstanding Range Over the Past 10 Years
Min: 42.28  Med: 50.35 Max: 58.05
Current: 54.87
42.28
58.05

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 0.37
UHS's Dividend Yield is ranked lower than
95% of the 257 Companies
in the Global Medical Care industry.

( Industry Median: 2.01 vs. UHS: 0.37 )
Ranked among companies with meaningful Dividend Yield only.
UHS' s Dividend Yield Range Over the Past 10 Years
Min: 0.17  Med: 0.50 Max: 0.99
Current: 0.37
0.17
0.99
Dividend Payout 0.06
UHS's Dividend Payout is ranked higher than
98% of the 146 Companies
in the Global Medical Care industry.

( Industry Median: 0.71 vs. UHS: 0.06 )
Ranked among companies with meaningful Dividend Payout only.
UHS' s Dividend Payout Range Over the Past 10 Years
Min: 0.03  Med: 0.07 Max: 0.53
Current: 0.06
0.03
0.53
Dividend Growth (3y) 14.50
UHS's Dividend Growth (3y) is ranked higher than
60% of the 67 Companies
in the Global Medical Care industry.

( Industry Median: 11.90 vs. UHS: 14.50 )
Ranked among companies with meaningful Dividend Growth (3y) only.
UHS' s Dividend Growth (3y) Range Over the Past 10 Years
Min: 0  Med: 0.00 Max: 58.7
Current: 14.5
0
58.7
Forward Dividend Yield 0.37
UHS's Forward Dividend Yield is ranked lower than
95% of the 217 Companies
in the Global Medical Care industry.

( Industry Median: 2.01 vs. UHS: 0.37 )
Ranked among companies with meaningful Forward Dividend Yield only.
N/A
Yield on cost (5-Year) 0.62
UHS's Yield on cost (5-Year) is ranked lower than
89% of the 261 Companies
in the Global Medical Care industry.

( Industry Median: 2.46 vs. UHS: 0.62 )
Ranked among companies with meaningful Yield on cost (5-Year) only.
UHS' s Yield on cost (5-Year) Range Over the Past 10 Years
Min: 0.29  Med: 0.84 Max: 1.66
Current: 0.62
0.29
1.66
3-Year Average Share Buyback Ratio -0.70
UHS's 3-Year Average Share Buyback Ratio is ranked higher than
67% of the 120 Companies
in the Global Medical Care industry.

( Industry Median: -2.20 vs. UHS: -0.70 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
UHS' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -1.6  Med: 0.90 Max: 6.8
Current: -0.7
-1.6
6.8

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 14.42
UHS's Price/Tangible Book is ranked lower than
93% of the 152 Companies
in the Global Medical Care industry.

( Industry Median: 3.38 vs. UHS: 14.42 )
Ranked among companies with meaningful Price/Tangible Book only.
UHS' s Price/Tangible Book Range Over the Past 10 Years
Min: 2.18  Med: 4.45 Max: 326.64
Current: 14.42
2.18
326.64
Price/Projected FCF 1.21
UHS's Price/Projected FCF is ranked higher than
59% of the 97 Companies
in the Global Medical Care industry.

( Industry Median: 1.34 vs. UHS: 1.21 )
Ranked among companies with meaningful Price/Projected FCF only.
UHS' s Price/Projected FCF Range Over the Past 10 Years
Min: 0.74  Med: 1.22 Max: 33.96
Current: 1.21
0.74
33.96
Price/DCF (Earnings Based) 0.66
UHS's Price/DCF (Earnings Based) is ranked higher than
96% of the 26 Companies
in the Global Medical Care industry.

( Industry Median: 1.58 vs. UHS: 0.66 )
Ranked among companies with meaningful Price/DCF (Earnings Based) only.
N/A
Price/Median PS Value 1.66
UHS's Price/Median PS Value is ranked lower than
84% of the 201 Companies
in the Global Medical Care industry.

( Industry Median: 1.02 vs. UHS: 1.66 )
Ranked among companies with meaningful Price/Median PS Value only.
UHS' s Price/Median PS Value Range Over the Past 10 Years
Min: 0.5  Med: 1.04 Max: 2.21
Current: 1.66
0.5
2.21
Price/Peter Lynch Fair Value 1.18
UHS's Price/Peter Lynch Fair Value is ranked higher than
86% of the 51 Companies
in the Global Medical Care industry.

( Industry Median: 2.67 vs. UHS: 1.18 )
Ranked among companies with meaningful Price/Peter Lynch Fair Value only.
UHS' s Price/Peter Lynch Fair Value Range Over the Past 10 Years
Min: 0.43  Med: 1.23 Max: 3.67
Current: 1.18
0.43
3.67
Price/Graham Number 3.22
UHS's Price/Graham Number is ranked lower than
74% of the 133 Companies
in the Global Medical Care industry.

( Industry Median: 2.06 vs. UHS: 3.22 )
Ranked among companies with meaningful Price/Graham Number only.
UHS' s Price/Graham Number Range Over the Past 10 Years
Min: 0.96  Med: 1.88 Max: 12.67
Current: 3.22
0.96
12.67
Earnings Yield (Greenblatt) (%) 9.30
UHS's Earnings Yield (Greenblatt) (%) is ranked higher than
88% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 4.40 vs. UHS: 9.30 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) (%) only.
UHS' s Earnings Yield (Greenblatt) (%) Range Over the Past 10 Years
Min: 5  Med: 9.10 Max: 16
Current: 9.3
5
16
Forward Rate of Return (Yacktman) (%) 18.27
UHS's Forward Rate of Return (Yacktman) (%) is ranked higher than
73% of the 101 Companies
in the Global Medical Care industry.

( Industry Median: 10.86 vs. UHS: 18.27 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) (%) only.
UHS' s Forward Rate of Return (Yacktman) (%) Range Over the Past 10 Years
Min: 10  Med: 19.10 Max: 28.1
Current: 18.27
10
28.1

More Statistics

Revenue(Mil) $8836
EPS $ 6.73
Beta0.84
Short Percentage of Float1.68%
52-Week Range $102.86 - 148.57
Shares Outstanding(Mil)98.47

Analyst Estimate

Dec15 Dec16 Dec17
Revenue(Mil) 9,411 10,073 10,691
EPS($) 6.78 7.42 8.13
EPS without NRI($) 6.78 7.42 8.13

Business Description

Industry: Health Care Providers » Medical Care
Compare:CHE, FMS, DVA, FSNUY, BDUUF » details
Traded in other countries:UHS.Germany, UHID.USA,
Universal Health Services Inc is a Delaware corporation organized in 1979. The Company through its subsidiaries is engaged in the business of owning and operating, acute care hospitals, behavioral health centers, surgical hospitals, ambulatory surgery centers and radiation oncology centers. The Company owned and/or operated 24 acute care hospitals and 193 behavioral health centers located in 37 states, Washington, D.C., Puerto Rico and the U.S. Virgin Islands. Services provided by hospitals include general and specialty surgery, internal medicine, obstetrics, emergency room care, radiology, oncology, diagnostic care, coronary care, pediatric services, pharmacy services and behavioral health services. The Company provides capital resources as well as management services to facilities, including central purchasing, information services, finance and control systems, facilities planning, physician recruitment services, administrative personnel management, marketing and public relations. The Company's reportable operating segments consist of acute care hospital services and behavioral health care services. The Other segment includes centralized services including information services, purchasing, reimbursement, accounting, taxation, legal, advertising, design and construction and patient accounting as well as the operating results for its other operating entities including outpatient surgery and radiation centers. All of the Company's acute care hospitals and its behavioral health centers are certified as providers of Medicare and Medicaid services by the appropriate governmental authorities. Medicare is a federal program that provides certain hospital and medical insurance benefits to persons aged 65 and over, some disabled persons and persons with end-stage renal disease. Medicaid is a joint federal-state funded health care benefit program that is administered by the states to provide benefits to qualifying individuals who are unable to afford care state Medicaid payments are made under a PPS-like system, or under programs that negotiate payment levels with individual hospitals. The Company's hospitals also provide services to individuals covered by private health care insurance. Private insurance carriers typically make direct payments to hospitals or, in some cases, reimburse their policy holders, based upon the particular hospital's established charges and the particular coverage provided in the insurance policy. Its hospitals provide services to individuals that do not have any form of health care coverage. Such patients are evaluated, at the time of service or shortly thereafter, for their ability to pay based upon federal and state poverty guidelines, qualifications for Medicaid or other state assistance programs, as well as its local hospital's indigent and charity care policy. The Company faces competition for acquisition candidates mainly from other for-profit health care companies, as well as from not-for-profit entities.
» More Articles for NYSE:UHS

Headlines

Articles On GuruFocus.com
Westport Select Cap Fund Third Quarter Commentary Oct 16 2015 
Westport Fund Third Quarter Commentary Oct 16 2015 
Olstein Funds 2015 Annual Letter to Shareholders Sep 24 2015 
Baron Funds Comments on Universal Health Services Inc. Aug 18 2015 
Westport Asset Management Sells Bulk of Two Stakes Aug 17 2015 
Mariko Gordon's Highest-Performing Stocks Jul 28 2015 
Westport Select Cap Fund Comments on Universal Health Services Inc May 29 2015 
Westport Funds Select Cap Fund Q3 Commentary Oct 25 2014 
Westport Asset Management’s Westport Select Cap Fund Third Quarter 2014 Commentary Oct 17 2014 
Westport Asset Management’s Westport Fund Third Quarter 2014 Commentary Oct 17 2014 

More From Other Websites
[$$] US investors lead dealmaking spree in British mental healthcare Feb 07 2016
Universal Health Services, Inc. To Present At The Leerink Partners 5th Annual Global Healthcare... Feb 05 2016
Trustee for defunct St. Pete health insurer sues Florida GOP Feb 03 2016
Universal Health Services, Inc. Announces Date For 2015 Fourth Quarter And Full Year Earnings... Jan 27 2016
Universal Health Services, Inc. Announces Date For 2015 Fourth Quarter And Full Year Earnings... Jan 27 2016
Universal Health Services, Inc. Announces Dividend Jan 20 2016
Universal Health Services, Inc. Announces Dividend Jan 20 2016
Health Costs Soar For Employers Outside The U.S. Jan 18 2016
Universal Health Services, Inc. To Present At The 34th Annual J.P. Morgan Healthcare Conference Jan 05 2016
Universal Health Services, Inc. To Present At The 34th Annual J.P. Morgan Healthcare Conference Jan 05 2016
Universal Health Services, Inc. breached its 50 day moving average in a Bullish Manner : December... Dec 30 2015
UNIVERSAL HEALTH SERVICES INC Files SEC form 8-K, Entry into a Material Definitive Agreement,... Dec 29 2015
Rising Concentration Points to New Risks Dec 28 2015
Alexion Pharmaceuticals: A Top Stock of SPY Dec 21 2015
Five Hospital Stocks to Buy Now Dec 20 2015
Developers of Rocklin psychiatric hospital hold meetings to defuse opposition Dec 08 2015
UNIVERSAL HEALTH SERVICES INC Financials Dec 08 2015
What Do Hedge Funds Think of Genuine Parts Company (GPC)? Dec 02 2015
Universal Health Services, Inc. breached its 50 day moving average in a Bullish Manner : December 2,... Dec 02 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK